Lower-dose start
A microdose start sized to your goals and tolerance.

Lower-Dose GLP-1 / Weekly Injection
A lower-and-slower GLP-1 start. A provider reviews appetite goals, prior use, tolerance, and medications before any dose is set.

Lower and slower
A lower start can ease early nausea while your provider watches how you respond before any increase.
A microdose start sized to your goals and tolerance.
Route comfort, dose history, and side-effect risk still matter.
A provider checks contraindications before treatment.
Why microdose
Tirzepatide acts on GLP-1 and GIP receptors. The microdose difference is the starting point — and how your tolerance is checked before any increase.

Cravings, portions, and prior GLP-1 use change the plan.

Same dual GIP + GLP-1 mechanism as the full dose — started lower and stepped up only as tolerated.

Dose history and side effects decide whether to hold, change, switch, or stop.

Your appetite goals, prior GLP-1 use, medications, and prescription decide the starting dose.

Charged today — ships if prescribed. Individual results vary.

Before it ships
Appetite response, side effects, and outcomes vary.
Dose history and tolerance should be checked before changes.
Contraindications, medications, and blood-sugar history matter.